Weitere Formate
Hardcover - 9783540857716
160,49 €
Autorenfreundlich Bücher kaufen?!
Beschreibung
Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy, including in particular the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life.
Details
| Verlag | Springer Berlin |
| Ersterscheinung | 30. Mai 2013 |
| Maße | 23.5 cm x 15.5 cm |
| Gewicht | 552 Gramm |
| Format | Softcover |
| ISBN-13 | 9783642267994 |
| Seiten | 340 |
Schlagwörter
Herstellerinformationen
Bekannt durch
